Diagnostic and therapy combinations involving identification of patients most likely to be helped or harmed by a medication and targeted drug therapy based on those results.
An example of theranostics is the breast cancer drug Herceptin that targets the protein HER2 overexpressed in some breast cancers. HercepTest and Pathy-Vysion are two diagnostic tests used to detect tumors susceptible to the treatment.
Cancer patients may be given two radioactive drugs, first one that recognizes tumor cell membranes that can serve as a target for cancer drugs. If the tumor lights up on a PET scan, another radioactive drug is given that kills the tumor cells.
Theranostic Nanomedicine applies nanobiotechnology, the creation and application of nanobiomaterials and devices, to medical intervention for diagnosing, curing or preventing diseases through personized medicine, imaging and therapy.
Synthetic molecular and cellular biosensors hold potential in theranostics, whereby gene circuits could act like an intracellular molecular prosthesis, monitoring disease-associated biomarkers and adjust therapeutic response accordingly.
- Nova TheraNostics
- Theranostics Health
- Stem Cell Theranostics
- A&G Pharmaceutical
- Theranostics Australia
- Biotheranostics
- Radiomedix
